Roubaix Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Roubaix Capital's RGEN Position: Q2 2026 in Review
Roubaix Capital sold out of Repligen (RGEN) in Q2 2026, closing a stake of 54,555 shares — an estimated $6.43M sold.
Roubaix Capital first reported a position in RGEN in Q2 2024 and held it in 4 quarters. The position peaked at $6.43M in Q1 2026. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Roubaix Capital reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
- Roubaix Capital sold 54,555 Repligen shares in Q2 2026, an estimated $6.43M.
- Roubaix Capital first reported a position in Repligen in Q2 2024 and held it in 4 quarters.
- Roubaix Capital's Repligen position peaked at $6.43M in Q1 2026.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Roubaix Capital's 13F filing for Q2 2026, filed 10 Aug 2026.